Finally, although most of the evidence of a potential benefit of GLP-1 RAs in HF originates from CVOTs in type 2 diabetes, it may likely be in the weight management setting that the drug class could be of the highest clinical value, particularly in people with HFpEF
Getting started is straightforward: schedule a telehealth visit, discuss your medical history and lipid panel results, and if appropriate, begin treatment immediately
Long-term outcomes after bariatric surgery: A systematic review and metaanalysis of weight loss at 10 or more years for all bariatric procedures and a single-centre review of 20-year outcomes after adjustable gastric banding
Zepbound should not be used with other GLP-1 receptor agonists, other tirzepatide products, or in combination with other prescription, over-the-counter, or herbal weight loss products, as these combinations have not been studied
J., Bleich, S
For self-starters who just want their meds without the extra fluff (or fees), its a solid pick
